NO823573L - Vevkulturmedium. - Google Patents

Vevkulturmedium.

Info

Publication number: NO823573L
Authority: NO; Norway
Prior art keywords: serum; stated; levels; cells; fetal calf
Prior art date: 1981-02-27

Application number

NO823573A

Other languages

English (en)

Norwegian (no)

Inventor

Ray Charles Carpenter

Orville Robert Cone Jr

Original Assignee

Amf Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-02-27

Filing date

1982-10-27

Publication date

1982-10-27

1982-10-27 Application filed by Amf Inc filed Critical Amf Inc

1982-10-27 Publication of NO823573L publication Critical patent/NO823573L/no

Links

239000003104 tissue culture media Substances 0.000 title claims description 10
210000002966 serum Anatomy 0.000 claims description 248
210000004027 cell Anatomy 0.000 claims description 135
108091003079 Bovine Serum Albumin Proteins 0.000 claims description 84
239000012894 fetal calf serum Substances 0.000 claims description 81
238000000034 method Methods 0.000 claims description 58
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 41
241000700605 Viruses Species 0.000 claims description 37
229910052814 silicon oxide Inorganic materials 0.000 claims description 24
150000003839 salts Chemical class 0.000 claims description 23
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 22
230000008569 process Effects 0.000 claims description 21
210000004698 lymphocyte Anatomy 0.000 claims description 19
238000004113 cell culture Methods 0.000 claims description 16
230000010261 cell growth Effects 0.000 claims description 16
230000001605 fetal effect Effects 0.000 claims description 16
241000283690 Bos taurus Species 0.000 claims description 15
108010074605 gamma-Globulins Proteins 0.000 claims description 15
238000000338 in vitro Methods 0.000 claims description 15
239000007788 liquid Substances 0.000 claims description 15
239000002158 endotoxin Substances 0.000 claims description 14
239000003610 charcoal Substances 0.000 claims description 13
JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 12
239000003517 fume Substances 0.000 claims description 11
238000004519 manufacturing process Methods 0.000 claims description 11
238000001556 precipitation Methods 0.000 claims description 11
102000001554 Hemoglobins Human genes 0.000 claims description 10
108010054147 Hemoglobins Proteins 0.000 claims description 10
108010088751 Albumins Proteins 0.000 claims description 9
241001465754 Metazoa Species 0.000 claims description 9
241000204031 Mycoplasma Species 0.000 claims description 9
239000012888 bovine serum Substances 0.000 claims description 9
102000002572 Alpha-Globulins Human genes 0.000 claims description 8
108010068307 Alpha-Globulins Proteins 0.000 claims description 8
102000006734 Beta-Globulins Human genes 0.000 claims description 7
108010087504 Beta-Globulins Proteins 0.000 claims description 7
102000004169 proteins and genes Human genes 0.000 claims description 7
108090000623 proteins and genes Proteins 0.000 claims description 7
238000000926 separation method Methods 0.000 claims description 7
229960000890 hydrocortisone Drugs 0.000 claims description 6
229910021645 metal ion Inorganic materials 0.000 claims description 6
102000006395 Globulins Human genes 0.000 claims description 5
108010044091 Globulins Proteins 0.000 claims description 5
229910021485 fumed silica Inorganic materials 0.000 claims description 5
210000004408 hybridoma Anatomy 0.000 claims description 5
239000000377 silicon dioxide Substances 0.000 claims description 5
210000004102 animal cell Anatomy 0.000 claims description 4
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 4
230000001376 precipitating effect Effects 0.000 claims description 3
239000000779 smoke Substances 0.000 claims description 3
239000011159 matrix material Substances 0.000 claims description 2
230000001954 sterilising effect Effects 0.000 claims description 2
238000004659 sterilization and disinfection Methods 0.000 claims description 2
102000009027 Albumins Human genes 0.000 claims 6
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims 1
229910001424 calcium ion Inorganic materials 0.000 claims 1
238000012606 in vitro cell culture Methods 0.000 claims 1
210000000265 leukocyte Anatomy 0.000 claims 1
238000011084 recovery Methods 0.000 claims 1
230000004936 stimulating effect Effects 0.000 claims 1
244000309466 calf Species 0.000 description 46
230000012010 growth Effects 0.000 description 38
241000699666 Mus <mouse, genus> Species 0.000 description 31
239000002609 medium Substances 0.000 description 19
102000014150 Interferons Human genes 0.000 description 14
108010050904 Interferons Proteins 0.000 description 14
239000012980 RPMI-1640 medium Substances 0.000 description 12
238000003786 synthesis reaction Methods 0.000 description 12
210000002950 fibroblast Anatomy 0.000 description 11
229940079322 interferon Drugs 0.000 description 11
239000000203 mixture Substances 0.000 description 11
210000004369 blood Anatomy 0.000 description 10
239000008280 blood Substances 0.000 description 10
239000001963 growth medium Substances 0.000 description 10
238000002360 preparation method Methods 0.000 description 10
210000001519 tissue Anatomy 0.000 description 10
238000004458 analytical method Methods 0.000 description 9
238000002474 experimental method Methods 0.000 description 9
235000012000 cholesterol Nutrition 0.000 description 8
238000011026 diafiltration Methods 0.000 description 8
230000000694 effects Effects 0.000 description 8
210000001161 mammalian embryo Anatomy 0.000 description 8
239000000047 product Substances 0.000 description 8
241000287828 Gallus gallus Species 0.000 description 7
BNQSTAOJRULKNX-UHFFFAOYSA-N N-(6-acetamidohexyl)acetamide Chemical compound CC(=O)NCCCCCCNC(C)=O BNQSTAOJRULKNX-UHFFFAOYSA-N 0.000 description 7
241000711975 Vesicular stomatitis virus Species 0.000 description 7
238000003556 assay Methods 0.000 description 7
238000005119 centrifugation Methods 0.000 description 7
231100000433 cytotoxic Toxicity 0.000 description 7
230000001472 cytotoxic effect Effects 0.000 description 7
238000001914 filtration Methods 0.000 description 7
230000006698 induction Effects 0.000 description 7
210000003734 kidney Anatomy 0.000 description 7
239000002356 single layer Substances 0.000 description 7
210000004989 spleen cell Anatomy 0.000 description 7
241000196324 Embryophyta Species 0.000 description 6
238000010790 dilution Methods 0.000 description 6
239000012895 dilution Substances 0.000 description 6
230000004927 fusion Effects 0.000 description 6
208000015181 infectious disease Diseases 0.000 description 6
230000009467 reduction Effects 0.000 description 6
239000000243 solution Substances 0.000 description 6
150000003431 steroids Chemical class 0.000 description 6
208000031637 Erythroblastic Acute Leukemia Diseases 0.000 description 5
208000036566 Erythroleukaemia Diseases 0.000 description 5
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
102000003996 Interferon-beta Human genes 0.000 description 5
108090000467 Interferon-beta Proteins 0.000 description 5
241000699673 Mesocricetus auratus Species 0.000 description 5
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
229930182558 Sterol Natural products 0.000 description 5
208000021841 acute erythroid leukemia Diseases 0.000 description 5
239000003245 coal Substances 0.000 description 5
210000001608 connective tissue cell Anatomy 0.000 description 5
210000002540 macrophage Anatomy 0.000 description 5
150000003432 sterols Chemical class 0.000 description 5
235000003702 sterols Nutrition 0.000 description 5
230000000638 stimulation Effects 0.000 description 5
239000000126 substance Substances 0.000 description 5
238000012360 testing method Methods 0.000 description 5
239000003053 toxin Substances 0.000 description 5
231100000765 toxin Toxicity 0.000 description 5
108700012359 toxins Proteins 0.000 description 5
230000009466 transformation Effects 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
241000894006 Bacteria Species 0.000 description 4
108010062580 Concanavalin A Proteins 0.000 description 4
241000699670 Mus sp. Species 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
239000000872 buffer Substances 0.000 description 4
239000012530 fluid Substances 0.000 description 4
238000005194 fractionation Methods 0.000 description 4
235000015097 nutrients Nutrition 0.000 description 4
239000002245 particle Substances 0.000 description 4
239000000575 pesticide Substances 0.000 description 4
150000003626 triacylglycerols Chemical class 0.000 description 4
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 4
-1 - glycerol phosphate Chemical compound 0.000 description 3
229910002012 Aerosil® Inorganic materials 0.000 description 3
102100027211 Albumin Human genes 0.000 description 3
241000867607 Chlorocebus sabaeus Species 0.000 description 3
AHJKRLASYNVKDZ-UHFFFAOYSA-N DDD Chemical compound C=1C=C(Cl)C=CC=1C(C(Cl)Cl)C1=CC=C(Cl)C=C1 AHJKRLASYNVKDZ-UHFFFAOYSA-N 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
102100034343 Integrase Human genes 0.000 description 3
102000008070 Interferon-gamma Human genes 0.000 description 3
108010074328 Interferon-gamma Proteins 0.000 description 3
102000003855 L-lactate dehydrogenase Human genes 0.000 description 3
108700023483 L-lactate dehydrogenases Proteins 0.000 description 3
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 3
210000003837 chick embryo Anatomy 0.000 description 3
238000000502 dialysis Methods 0.000 description 3
230000004069 differentiation Effects 0.000 description 3
229940088598 enzyme Drugs 0.000 description 3
239000012091 fetal bovine serum Substances 0.000 description 3
239000003102 growth factor Substances 0.000 description 3
210000003958 hematopoietic stem cell Anatomy 0.000 description 3
239000005556 hormone Substances 0.000 description 3
229940088597 hormone Drugs 0.000 description 3
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
239000000411 inducer Substances 0.000 description 3
239000002917 insecticide Substances 0.000 description 3
229940047124 interferons Drugs 0.000 description 3
238000012423 maintenance Methods 0.000 description 3
239000003226 mitogen Substances 0.000 description 3
244000144977 poultry Species 0.000 description 3
238000012545 processing Methods 0.000 description 3
229910052938 sodium sulfate Inorganic materials 0.000 description 3
235000011152 sodium sulphate Nutrition 0.000 description 3
238000001179 sorption measurement Methods 0.000 description 3
210000000952 spleen Anatomy 0.000 description 3
231100000419 toxicity Toxicity 0.000 description 3
TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
229920001817 Agar Polymers 0.000 description 2
102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
201000009030 Carcinoma Diseases 0.000 description 2
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 2
229920000209 Hexadimethrine bromide Polymers 0.000 description 2
208000031226 Hyperlipidaemia Diseases 0.000 description 2
108090001030 Lipoproteins Proteins 0.000 description 2
102000004895 Lipoproteins Human genes 0.000 description 2
206010035226 Plasma cell myeloma Diseases 0.000 description 2
239000012979 RPMI medium Substances 0.000 description 2
206010038802 Reticuloendothelial system stimulated Diseases 0.000 description 2
241000712909 Reticuloendotheliosis virus Species 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
239000013504 Triton X-100 Substances 0.000 description 2
229920004890 Triton X-100 Polymers 0.000 description 2
239000008272 agar Substances 0.000 description 2
229960003896 aminopterin Drugs 0.000 description 2
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
229910052921 ammonium sulfate Inorganic materials 0.000 description 2
239000001166 ammonium sulphate Substances 0.000 description 2
235000011130 ammonium sulphate Nutrition 0.000 description 2
229960000074 biopharmaceutical Drugs 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
239000011575 calcium Substances 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
230000030833 cell death Effects 0.000 description 2
230000032823 cell division Effects 0.000 description 2
230000007910 cell fusion Effects 0.000 description 2
210000003679 cervix uteri Anatomy 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
238000010367 cloning Methods 0.000 description 2
239000000470 constituent Substances 0.000 description 2
238000012258 culturing Methods 0.000 description 2
230000002354 daily effect Effects 0.000 description 2
238000004090 dissolution Methods 0.000 description 2
238000009826 distribution Methods 0.000 description 2
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
239000003792 electrolyte Substances 0.000 description 2
210000003743 erythrocyte Anatomy 0.000 description 2
239000000262 estrogen Substances 0.000 description 2
235000019441 ethanol Nutrition 0.000 description 2
230000003203 everyday effect Effects 0.000 description 2
239000000835 fiber Substances 0.000 description 2
239000012737 fresh medium Substances 0.000 description 2
JLYXXMFPNIAWKQ-GNIYUCBRSA-N gamma-hexachlorocyclohexane Chemical compound Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl JLYXXMFPNIAWKQ-GNIYUCBRSA-N 0.000 description 2
238000002523 gelfiltration Methods 0.000 description 2
238000005469 granulation Methods 0.000 description 2
230000003179 granulation Effects 0.000 description 2
230000036541 health Effects 0.000 description 2
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
230000003100 immobilizing effect Effects 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
238000002955 isolation Methods 0.000 description 2
229960002809 lindane Drugs 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
210000004072 lung Anatomy 0.000 description 2
239000012528 membrane Substances 0.000 description 2
201000000050 myeloid neoplasm Diseases 0.000 description 2
238000002962 plaque-reduction assay Methods 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
230000002062 proliferating effect Effects 0.000 description 2
230000035755 proliferation Effects 0.000 description 2
230000006920 protein precipitation Effects 0.000 description 2
230000009666 qualitative growth Effects 0.000 description 2
LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Chemical class [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 2
239000002002 slurry Substances 0.000 description 2
239000011734 sodium Substances 0.000 description 2
239000003270 steroid hormone Substances 0.000 description 2
238000003756 stirring Methods 0.000 description 2
229940104230 thymidine Drugs 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
238000012546 transfer Methods 0.000 description 2
238000000844 transformation Methods 0.000 description 2
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
230000035899 viability Effects 0.000 description 2
238000003260 vortexing Methods 0.000 description 2
IQFYYKKMVGJFEH-OFKYTIFKSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(tritiooxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound C1[C@H](O)[C@@H](CO[3H])O[C@H]1N1C(=O)NC(=O)C(C)=C1 IQFYYKKMVGJFEH-OFKYTIFKSA-N 0.000 description 1
IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 1
QEBNVGLWXKVRJR-UHFFFAOYSA-N 2-(4,5-dimethyl-1,3-diselenol-2-ylidene)-5,6-dihydro-[1,3]dithiolo[4,5-b][1,4]dithiine Chemical compound [Se]1C(C)=C(C)[Se]C1=C1SC(SCCS2)=C2S1 QEBNVGLWXKVRJR-UHFFFAOYSA-N 0.000 description 1
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
241000272525 Anas platyrhynchos Species 0.000 description 1
208000035404 Autolysis Diseases 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
235000018185 Betula X alpestris Nutrition 0.000 description 1
235000018212 Betula X uliginosa Nutrition 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
244000025254 Cannabis sativa Species 0.000 description 1
206010057248 Cell death Diseases 0.000 description 1
229920003043 Cellulose fiber Polymers 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
102000000989 Complement System Proteins Human genes 0.000 description 1
108010069112 Complement System Proteins Proteins 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
QRLVDLBMBULFAL-UHFFFAOYSA-N Digitonin Natural products CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C8O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C QRLVDLBMBULFAL-UHFFFAOYSA-N 0.000 description 1
239000012983 Dulbecco’s minimal essential medium Substances 0.000 description 1
229930186217 Glycolipid Natural products 0.000 description 1
239000007995 HEPES buffer Substances 0.000 description 1
102000018251 Hypoxanthine Phosphoribosyltransferase Human genes 0.000 description 1
108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
241000239218 Limulus Species 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
241001529936 Murinae Species 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
208000012868 Overgrowth Diseases 0.000 description 1
239000007990 PIPES buffer Substances 0.000 description 1
241001504519 Papio ursinus Species 0.000 description 1
108091036414 Polyinosinic:polycytidylic acid Proteins 0.000 description 1
LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
102000004338 Transferrin Human genes 0.000 description 1
108090000901 Transferrin Proteins 0.000 description 1
GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
238000013019 agitation Methods 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
229920006318 anionic polymer Polymers 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
238000012742 biochemical analysis Methods 0.000 description 1
210000002798 bone marrow cell Anatomy 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
230000004856 capillary permeability Effects 0.000 description 1
229920006317 cationic polymer Polymers 0.000 description 1
230000022131 cell cycle Effects 0.000 description 1
230000036978 cell physiology Effects 0.000 description 1
230000010307 cell transformation Effects 0.000 description 1
230000003833 cell viability Effects 0.000 description 1
230000007541 cellular toxicity Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
238000005352 clarification Methods 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
239000005515 coenzyme Substances 0.000 description 1
230000002281 colonystimulating effect Effects 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
238000010924 continuous production Methods 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
230000000875 corresponding effect Effects 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
230000016396 cytokine production Effects 0.000 description 1
238000010908 decantation Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
229960000633 dextran sulfate Drugs 0.000 description 1
239000000385 dialysis solution Substances 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 description 1
UVYVLBIGDKGWPX-UHFFFAOYSA-N digitonine Natural products CC1C(C2(CCC3C4(C)CC(O)C(OC5C(C(O)C(OC6C(C(OC7C(C(O)C(O)CO7)O)C(O)C(CO)O6)OC6C(C(OC7C(C(O)C(O)C(CO)O7)O)C(O)C(CO)O6)O)C(CO)O5)O)CC4CCC3C2C2O)C)C2OC11CCC(C)CO1 UVYVLBIGDKGWPX-UHFFFAOYSA-N 0.000 description 1
210000001840 diploid cell Anatomy 0.000 description 1
238000007598 dipping method Methods 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000000428 dust Substances 0.000 description 1
239000012636 effector Substances 0.000 description 1
210000002257 embryonic structure Anatomy 0.000 description 1
108010072542 endotoxin binding proteins Proteins 0.000 description 1
238000011013 endotoxin removal Methods 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
208000037828 epithelial carcinoma Diseases 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
239000010685 fatty oil Substances 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
238000009950 felting Methods 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
239000011152 fibreglass Substances 0.000 description 1
230000003328 fibroblastic effect Effects 0.000 description 1
210000003953 foreskin Anatomy 0.000 description 1
238000009472 formulation Methods 0.000 description 1
125000002642 gamma-glutamyl group Chemical group 0.000 description 1
239000003365 glass fiber Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
239000008187 granular material Substances 0.000 description 1
210000003714 granulocyte Anatomy 0.000 description 1
230000003394 haemopoietic effect Effects 0.000 description 1
229910001385 heavy metal Inorganic materials 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000036039 immunity Effects 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
239000002799 interferon inducing agent Substances 0.000 description 1
239000000543 intermediate Substances 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
238000009630 liquid culture Methods 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
229910052748 manganese Inorganic materials 0.000 description 1
239000011572 manganese Substances 0.000 description 1
229940071125 manganese acetate Drugs 0.000 description 1
UOGMEBQRZBEZQT-UHFFFAOYSA-L manganese(2+);diacetate Chemical compound [Mn+2].CC([O-])=O.CC([O-])=O UOGMEBQRZBEZQT-UHFFFAOYSA-L 0.000 description 1
201000006512 mast cell neoplasm Diseases 0.000 description 1
208000006971 mastocytoma Diseases 0.000 description 1
239000000463 material Substances 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
230000002906 microbiologic effect Effects 0.000 description 1
238000005497 microtitration Methods 0.000 description 1
230000002297 mitogenic effect Effects 0.000 description 1
238000004264 monolayer culture Methods 0.000 description 1
PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
229930014626 natural product Natural products 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
230000020477 pH reduction Effects 0.000 description 1
239000013618 particulate matter Substances 0.000 description 1
230000007170 pathology Effects 0.000 description 1
239000008188 pellet Substances 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
238000007747 plating Methods 0.000 description 1
231100000614 poison Toxicity 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
150000003071 polychlorinated biphenyls Chemical class 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
229940115272 polyinosinic:polycytidylic acid Drugs 0.000 description 1
108091033319 polynucleotide Proteins 0.000 description 1
239000002157 polynucleotide Substances 0.000 description 1
102000040430 polynucleotide Human genes 0.000 description 1
230000021625 positive regulation of cell division Effects 0.000 description 1
230000034918 positive regulation of cell growth Effects 0.000 description 1
229910000160 potassium phosphate Inorganic materials 0.000 description 1
235000011009 potassium phosphates Nutrition 0.000 description 1
239000000843 powder Substances 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
230000007026 protein scission Effects 0.000 description 1
230000001698 pyrogenic effect Effects 0.000 description 1
230000009663 quantitative growth Effects 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
239000001044 red dye Substances 0.000 description 1
238000007670 refining Methods 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
238000002976 reverse transcriptase assay Methods 0.000 description 1
201000009410 rhabdomyosarcoma Diseases 0.000 description 1
238000005070 sampling Methods 0.000 description 1
230000028043 self proteolysis Effects 0.000 description 1
239000012679 serum free medium Substances 0.000 description 1
RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
239000010703 silicon Substances 0.000 description 1
238000003307 slaughter Methods 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
229940048086 sodium pyrophosphate Drugs 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000007711 solidification Methods 0.000 description 1
230000008023 solidification Effects 0.000 description 1
241000894007 species Species 0.000 description 1
230000003393 splenic effect Effects 0.000 description 1
239000007858 starting material Substances 0.000 description 1
238000011146 sterile filtration Methods 0.000 description 1
239000000758 substrate Substances 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
238000004448 titration Methods 0.000 description 1
239000003440 toxic substance Substances 0.000 description 1
239000012581 transferrin Substances 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
238000000108 ultra-filtration Methods 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
229940116269 uric acid Drugs 0.000 description 1
238000007666 vacuum forming Methods 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000000341 volatile oil Substances 0.000 description 1
239000002699 waste material Substances 0.000 description 1
239000001993 wax Substances 0.000 description 1
239000002023 wood Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Cell Biology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Materials For Medical Uses (AREA)
Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating Or Analysing Biological Materials (AREA)

NO823573A 1981-02-27 1982-10-27 Vevkulturmedium. NO823573L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US23868681A	1981-02-27	1981-02-27
US06/349,691 US4473647A (en)	1981-02-27	1982-02-17	Tissue culture medium

Publications (1)

Publication Number	Publication Date
NO823573L true NO823573L (no)	1982-10-27

Family

ID=26931865

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO823573A NO823573L (no)	1981-02-27	1982-10-27	Vevkulturmedium.

Country Status (8)

Country	Link
US (1)	US4473647A (da)
EP (1)	EP0072864A4 (da)
JP (1)	JPS58500273A (da)
BR (1)	BR8206515A (da)
CA (1)	CA1199578A (da)
DK (1)	DK474882A (da)
NO (1)	NO823573L (da)
WO (1)	WO1982002900A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4533634A (en) *	1983-01-26	1985-08-06	Amf Inc.	Tissue culture medium
AU2492084A (en) *	1983-01-26	1984-08-15	Amf Inc.	Tissue culture medium
JPS60145088A (ja) *	1984-01-07	1985-07-31	Agency Of Ind Science & Technol	動物細胞培養用組成物の製造法
DE3586946D1 (de) *	1984-06-22	1993-02-11	Richard L Veech	Elektrolytloesungen und deren in-vitro-verwendung.
ATE82500T1 (de) *	1984-06-22	1992-12-15	Richard L Veech	Elektrolytloesungen und deren (in vivo) verwendung.
FR2572093A1 (fr) *	1984-10-22	1986-04-25	Anda Biolog	Nouveau milieu de culture cellulaire contenant des cellules de rate humaine, procede de culture utilisant ce milieu de culture, lignees de cellules lymphoblastoides obtenues, application a la production d'interferon, procede de preparation d'interferon et interferon ainsi produit
US4757018A (en) *	1985-02-11	1988-07-12	Hazleton Biotechnologies, Inc.	Myeloma cell lines and uses thereof
EP0230430A4 (en) *	1985-06-12	1989-03-09	Luminis Pty Ltd	CULTURE MEDIUM FOR FERTILIZATION -i (IN VITRO) AND TRANSFER OF EMBRYOS.
US5955581A (en) *	1986-11-10	1999-09-21	Biopure Corporation	Method for producing a stable polymerized hemoglobin blood-substitute
US5753616A (en) *	1986-11-10	1998-05-19	Biopure Corporation	Method for producing a stable polymerized hemoglobin blood-substitute
DE69002657T2 (de) *	1989-02-06	1994-03-24	Den Ichi Mizuno	Limulustest-positives Pflanzenglykolipid und Verfahren zur Stimulierung des Immunsystems eines Tieres.
US5637450A (en) *	1990-04-18	1997-06-10	Bohn; Burghard	Decontaminated serum and method of production therefor
WO1992015670A1 (en) *	1991-02-28	1992-09-17	Hyclone Laboratories, Inc.	Blended bovine sera cellular growth media and their methods of production and use
FI91166C (fi) *	1991-10-17	1994-05-25	Valio Biotuotteet Oy	Ternimaitofraktio, menetelmä sen valmistamiseksi ja sen käyttö kasvualustojen täydennysaineena
NL9401535A (nl) *	1994-09-21	1996-05-01	Stichting Scheikundig Onderzoe	Uit serum bereid eiwitmengsel voor het gebruik als component in media voor het in vitro kweken van dierlijke cellen.
US6150507A (en) *	1995-03-23	2000-11-21	Biopure Corporation	Method for producing a purified hemoglobin product
CN1098352C (zh) *	1996-12-05	2003-01-08	中国医学科学院皮肤病研究所	高效支原体培养基及其制备方法
US6056951A (en)	1997-10-07	2000-05-02	Torres; Anthony R.	Method of reducing the chance of attack of cells in a body by the cellular immune system
DE10103211C1 (de) *	2001-01-24	2002-07-18	Ursula Kastner	Kulturmedium
CA2480121C (en) *	2002-03-27	2012-02-28	Immunex Corporation	Methods for increasing polypeptide production
DK1449535T3 (da) *	2003-02-18	2006-09-11	Clinique La Prairie Res Sa	Præparater der omfatter fötalt hæmoglobin og bakterieendotoksin samt eventuelt fötale leverbestanddele
US7056747B2 (en) *	2004-08-13	2006-06-06	Dade Behring Inc.	Process for removing endogenous Vitamin B12 and folate from albumin preparations
US20070099245A1 (en) *	2005-09-29	2007-05-03	Boris Gorovits	Assays for neutralizing antibodies
CN116718455A (zh) *	2023-05-29	2023-09-08	深圳瑞亚力集团有限公司	一种牛血清中脂类脱脂方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3128228A (en) *	1960-03-04	1964-04-07	Ustav Ser A Ockovacich Latek	Tissue culture medium
US3122476A (en) *	1960-06-21	1964-02-25	Hyland Lab	Tissue culture medium
US3429867A (en) *	1965-04-30	1969-02-25	Microbiological Ass Inc	Serum substantially free from gamma globulin and method of preparing same
NL6702923A (da) *	1966-04-06	1967-10-09
DE2459291C3 (de) *	1974-12-14	1981-06-04	Biotest-Serum-Institut Gmbh, 6000 Frankfurt	Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen
US4059512A (en) *	1974-12-27	1977-11-22	Preventive Systems, Inc.	Process for removing endotoxin from biological fluids
US4007008A (en) *	1975-07-30	1977-02-08	Becker Milton J	Preparation of reference serum from animal blood
US4038139A (en) *	1976-07-16	1977-07-26	G. D. Searle & Co., Limited	Cell culture medium
US4136094A (en) *	1977-08-31	1979-01-23	The Regents Of The University Of Minnesota	Preparation of intravenous human and animal gamma globulins and isolation of albumin

1982
- 1982-02-17 US US06/349,691 patent/US4473647A/en not_active Expired - Lifetime
- 1982-02-26 CA CA000397226A patent/CA1199578A/en not_active Expired
- 1982-03-01 WO PCT/US1982/000247 patent/WO1982002900A1/en not_active Ceased
- 1982-03-01 JP JP57501351A patent/JPS58500273A/ja active Pending
- 1982-03-01 BR BR8206515A patent/BR8206515A/pt unknown
- 1982-03-01 EP EP19820901193 patent/EP0072864A4/en not_active Ceased
- 1982-10-26 DK DK474882A patent/DK474882A/da not_active Application Discontinuation
- 1982-10-27 NO NO823573A patent/NO823573L/no unknown

Also Published As

Publication number	Publication date
EP0072864A4 (en)	1983-05-16
WO1982002900A1 (en)	1982-09-02
JPS58500273A (ja)	1983-02-24
DK474882A (da)	1982-10-26
US4473647A (en)	1984-09-25
CA1199578A (en)	1986-01-21
BR8206515A (pt)	1983-01-25
EP0072864A1 (en)	1983-03-02

Publication	Publication Date	Title
NO823573L (no)	1982-10-27	Vevkulturmedium.
US4533634A (en)	1985-08-06	Tissue culture medium
Konigsberg	1979	[45] Skeletal myoblasts in culture
EP0413727B1 (en)	1994-06-15	Blood platelet lysate, method of its preparation and a cell culture medium containing said blood platelet lysate
JP2010535499A (ja)	2010-11-25	真核細胞用の培地
US3887430A (en)	1975-06-03	Culture medium for tissue culture techniques
US20230272337A1 (en)	2023-08-31	Yolk extract supplements for culture media and related methods
Maurizi et al.	1983	Morphological and functional characteristics of human temporal-bone cell cultures
US4055466A (en)	1977-10-25	Culture medium for tissue culture techniques
CA1198993A (en)	1986-01-07	Tissue culture and cell growth promoting material and its method of manufacture
EP0115284A2 (en)	1984-08-08	Tissue culture medium
AU8338082A (en)	1982-09-14	Tissue culture medium
US4189535A (en)	1980-02-19	Serum cell growth promoting materials
Franks	1980	Primary cultures of human prostate
LINDSAY	1991	peripheral neurons
EP0148770B1 (en)	1991-12-11	Composition for cell cultivation, production and use thereof
US4436816A (en)	1984-03-13	Cell growth promoting material
JP2004008130A (ja)	2004-01-15	細胞培養用無血清培地
堀内浩幸 et al.	1990	Preliminary evidence of growth factor (s) from chicken thrombocytes. Growth effects on chicken embryo fibroblasts culture.
RU2236457C2 (ru)	2004-09-20	Способ получения питательной среды "лимфокар" для культивирования лимфоцитов периферической крови человека и животных
CN116694571A (zh)	2023-09-05	一种无异种t细胞培养基及其制备方法和应用
KR880002318B1 (ko)	1988-10-22	무혈청 배지
AU2005315612A1 (en)	2006-06-22	Peptide fractions promoting growth and synthesis of desired product(s) into cell and/or tissue culture
JPS62278979A (ja)	1987-12-03	動物細胞の培養方法
O'Neil	1958	A Simplified Medium for Use in Tissue Cultivation of Poliomyelitis Virus